2 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection Posaconazole 100 MG [Noxafil], Posaconazole 40 MG/ML - Cystic Fibrosis, Aspergillosis | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 135 | 2021-04-22 | 2021-07-19 |
| Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops - Infection, Fungal | Phase 2 / Phase 3 | Unknown | L.V. Prasad Eye Institute | 55 | 2017-01-01 | 2017-07-26 |
Aspergillosis (1) · Cystic Fibrosis (1) · Mycoses (1) · Reinfection (1)
Bambino Gesù Hospital and Research Institute (1) · L.V. Prasad Eye Institute (1)
Czechia (1) · France (1) · Germany (1) · Greece (1) · India (1) · Ireland (1) · Italy (1) · Netherlands (1) · Portugal (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
2019 (1)